Company intelligence / Profile preview
XBiotech Inc.
Austin, Texas, United Statesxbiotech.com ↗
- Ownership
- Public · XBIT
- Development stage
- Phase 2
01
Overview
XBiotech develops therapeutic antibodies derived from natural human immunity using its proprietary True Human™ technology. The company’s lead clinical results include a Phase 1/2 study in advanced pancreatic cancer showing trends for reduced toxicities and better outcomes when combining ONIVYDE/5-FU with their targeted anti–IL‑1 alpha therapy. Their rheumatology program was recently paused following unexpected study findings. The company continues to expand R&D capabilities to support ongoing infectious disease and commercialization efforts.[1][3][6]
- Therapeutic areas
- OncologyCardiovascularInfectious DiseasesRheumatology
- Modalities
- Monoclonal antibodies (mAbs)True Human™ antibodies[1][3][5]
- Industry
- Biotech
02
Drug pipeline
5 assets4 more assets in the full pipeline.
03
Financials
- Market cap
- $57M
- Total revenue
- $0
- Enterprise value
- $-52.5M
Beyond the preview
Go deeper on XBiotech Inc..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on XBiotech Inc..